Skip to main content
Clinical Trials/CTRI/2024/03/064687
CTRI/2024/03/064687Not yet recruitingPhase 2/3

Efficacy of Tiladi Churna (orally) with Vidangadi Lepa in the Management of Dadru Kushtha- a Open Label Randomised Standard Control Study

All India Institute Of Ayurveda1 site in 1 country72 target enrollmentStarted: April 15, 2024Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Enrollment
72
Locations
1
Primary Endpoint
Resolution in the sign and symptoms of Dadru kushtha

Study Overview

Brief Summary

There are eighteen types of Kushtha Roga which are classified into Maha Kushtha and Kshudra Kushtha. Dadru is classified as a Kshudra Kushtha by ’Acharya Charaka’ and MahaKushtha  by ’Acharya  Sushruta’. Mithya Ahara Vihar is the main cause of Kushtha Roga.

AIM:

a) To compare the efficacy of Tiladi churna (orally) with Vidangadi Lepa (L/A)  and Tiladi churna (orally) with Terbinafine Ointment (L/A)  in management of Dadru Kushtha .

b) To determine Anti-fungal effect of Vidangadi lepa in Dadru Kustha through Sensitivity.

 OBJECTIVES: PRIMARY:

•         To compare the efficacy of Vidangadi lepa and Terbinafine Ointment externally with Tiladi churna internally in both group in the management of Dadru Kushtha.

SECONDARY:

•         To observe and determine the growth of fungus in Dadru kushtha by culture study.

•         To observe the Antifungal effect of Vidangadi lepa  through sensitivity.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient with classical sign and symptoms of Dadru Kushtha Patients willing to participate.

Exclusion Criteria

  • Patients suffering from Systemic Disorders, uncontrolled DM, HIV, Hepatitis- B, malignancy.
  • Cases of Burn.
  • Known cases of any other skin disease.
  • Any allergic condition related to skin and hypersensitivity to any medicine.
  • Pregnant and lactating women.

Outcomes

Primary Outcomes

Resolution in the sign and symptoms of Dadru kushtha

Time Frame: Assessment of sign and symptoms of dadru kushtha at baseline,30th day,60th day

Secondary Outcomes

  • •To observe & determine the growth of fungus in Dadru kushtha by culture study.(•To observe the Antifungal effect of Vidangadi lepa through sensitivity)

Investigators

Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Tadhani Piyush Lakhmanbhai

All India Institute Of Ayurveda

Study Sites (1)

Loading locations...

Similar Trials